A placebo controlled-crossover study of synthetic thyrotropin-releasing hormone in breast and prostate cancer patients

Description:
Dr. Andrew Winokur at the University of Connecticut Health center is currently conducting a study on cancer-related fatigue (CRF). Eligible participants will receive an investigational medication and a placebo for the treatment of CRF. Medication, medical and psychiatric evaluations will also be provided to participants at no cost.